Society for Neuro-Oncology Abstract

Nov 9

Written By Kyle Kingma

Kyle Kingma

EMulate Therapeutics Inc. Announces Publication of Clinical Results at the SNO 2023 Conference: GBM and DIPG

EMulate Therapeutics Announces the Publication of Its Phase I/II Results in CNS Oncology: “An Expanded Safety/Feasibility Study of the EMulate Therapeutics Voyager in Patients with Recurrent GBM”